相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and Safety of Drugs for Gastroparesis: Systematic Review and Network Meta-analysis
Maria Rosa Ingrosso et al.
GASTROENTEROLOGY (2023)
Do prokinetic agents provide symptom relief through acceleration of gastric emptying? An update and revision of the existing evidence
Nick Goelen et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2023)
Neural networks involved in nausea in adult humans: A systematic review
C. Varangot-Reille et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2023)
Aprepitant is a novel, selective activator of the K2P channel TRAAK
D. McCoull et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)
Clinical trial: a single-centre, randomised, controlled trial of tradipitant on satiation, gastric functions, and serum drug levels in healthy volunteers
Lehar Khanna et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)
A multi-parameter approach to measurement of spontaneous myogenic contractions in human stomach: Utilization to assess potential modulators of myogenic contractions
Marilisa Straface et al.
PHARMACOLOGICAL RESEARCH (2022)
ACG Clinical Guideline: Gastroparesis
Michael Camilleri et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)
Proximal and distal intragastric meal distribution during gastric emptying scintigraphy: Relationships to symptoms of gastroparesis
Paul J. Silver et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2022)
A proposal for rational drug class terminology: A gastrointestinal perspective
Gareth J. Sanger et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Synergistic augmentation of rhythmic myogenic contractions of human stomach by arginine vasopressin and adrenaline: Implications for the induction of nausea
Raj Makwana et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control
Ryan J. Jalleh et al.
DIABETOLOGIA (2022)
Efficacy and Safety of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Randomized, Placebo-Controlled Trial
Jesse L. Carlin et al.
GASTROENTEROLOGY (2021)
Nausea and Vomiting in 2021 A Comprehensive Update
Matthew Heckroth et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2021)
Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features
Pankaj J. Pasricha et al.
GASTROENTEROLOGY (2021)
Retrograde slow-wave activation: a missing link in gastric dysfunction?
Greg O'Grady et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2021)
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis
Jolien Schol et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)
The gastric conduction system in health and disease: a translational review
Gregory O'Grady et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2021)
Preclinical Evaluation of the Effects of Trazpiroben (TAK-906), a Novel, Potent Dopamine D2/D3 Receptor Antagonist for the Management of Gastroparesis
Roger L. Whiting et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia
Lucas Wauters et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2021)
Randomised study: effects of the 5-HT4 receptor agonist felcisetrag vs placebo on gut transit in patients with gastroparesis
Victor Chedid et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Autonomic function in gastroparesis and chronic unexplained nausea and vomiting: Relationship with etiology, gastric emptying, and symptom severity
Linda Nguyen et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2020)
Marijuana, Ondansetron, and Promethazine Are Perceived as Most Effective Treatments for Gastrointestinal Nausea
Thomas A. Zikos et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates
Danna M. Breen et al.
CELL METABOLISM (2020)
Effects of Promotility Agents on Gastric Emptying and Symptoms: A Systematic Review and Meta-analysis
Priya Vijayvargiya et al.
GASTROENTEROLOGY (2019)
784 – Velusetrag Improves Gastoparesis Both in Symptoms and Gastric Emptying in Patients with Diabetic Or Idiopathic Gastroparesis in a 12-Week Global Phase 2B Study
Thomas Abell et al.
GASTROENTEROLOGY (2019)
Acute dystonic reaction induced by a single dose of clebopride A case report
Young Woo Seo et al.
MEDICINE (2019)
Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited
Ahmad Al‐Saffar et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2019)
An Atlas of Vagal Sensory Neurons and Their Molecular Specialization
Jussi Kupari et al.
CELL REPORTS (2019)
Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study
Florencia Carbone et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Gastroprokinetic agent, mosapride inhibits 5-HT3 receptor currents in NCB-20 cells
Yong Soo Park et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2019)
The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function
John F. Golding et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Aprepitant Has Mixed Effects on Nausea and Reduces Other Symptoms in Patients With Gastroparesis and Related Disorders
Pankaj J. Pasricha et al.
GASTROENTEROLOGY (2018)
A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research
Gareth J. Sanger et al.
FRONTIERS IN PHARMACOLOGY (2018)
Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT3 Antagonist, Palonosetron and With the NK1 Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew)
John A. Rudd et al.
FRONTIERS IN PHARMACOLOGY (2018)
The effect of mirtazapine on gastric accommodation, gastric sensitivity to distention, and nutrient tolerance in healthy subjects
F. Carbone et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2017)
Mirtazapine for symptom control in refractory gastroparesis
Mark Malamood et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant
Deepti Jacob et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)
Studies To Examine Potential Tolerability Differences between the 5-HT2C Receptor Selective Agonists Lorcaserin and CP-809101
Guy A. Higgins et al.
ACS CHEMICAL NEUROSCIENCE (2017)
The Burdens, Concerns, and Quality of Life of Patients with Gastroparesis
Daohai Yu et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study
G. Palareti et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2016)
Ghrelin and motilin receptors as drug targets for gastrointestinal disorders
Gareth J. Sanger et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Toward a Better Drug for Gastroparesis: The Problem With a Moving Target
Pankaj Jay Pasricha et al.
GASTROENTEROLOGY (2016)
Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis
Anthony Lembo et al.
GASTROENTEROLOGY (2016)
NG101: A Potent and Selective Dopamine D2 Receptor Antagonist as a Potential Alternative to Metoclopramide and Domperidone for the Treatment of Gastroparesis
Cyril De Colle et al.
GASTROENTEROLOGY (2016)
The effect of levosulpiride on in vitro motor patterns in the human gastric fundus, antrum, and jejunum
D. Gallego et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2016)
Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis
J. Tack et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2016)
Nausea and vomiting in gastroparesis: similarities and differences in idiopathic and diabetic gastroparesis
H. P. Parkman et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2016)
Granisetron Transdermal System for Treatment of Symptoms of Gastroparesis: A Prescription Registry Study
Deena Midani et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2016)
Symptomatic Improvement of Gastroparesis with Granisetron Transdermal System
Hye-Kyung Jung
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2016)
Drug-drug interactions in pharmacologic management of gastroparesis
A. S. Youssef et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2015)
The Relationship Between Symptom Improvement and Gastric Emptying in the Treatment of Gastroparesis: Remember the Pharmacology
G. J. Sanger
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Granisetron Transdermal System Improves Refractory Nausea and Vomiting in Gastroparesis
Kellie Simmons et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Nausea and the quest for the perfect anti-emetic
Paul L. R. Andrews et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Drugs acting at 5-HT4, D2, motilin, and ghrelin receptors differ markedly in how they affect neuromuscular functions in human isolated stomach
J. Broad et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
TACHYKININS AND THEIR RECEPTORS: CONTRIBUTIONS TO PHYSIOLOGICAL CONTROL AND THE MECHANISMS OF DISEASE
Martin S. Steinhoff et al.
PHYSIOLOGICAL REVIEWS (2014)
Rapid improvement in post-infectious gastroparesis symptoms with mirtazapine
Shinjini Kundu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Clinical Guideline: Management of Gastroparesis
Michael Camilleri et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
The Relation Between Symptom Improvement and Gastric Emptying in the Treatment of Diabetic and Idiopathic Gastroparesis
Pieter Janssen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists
G. J. Sanger et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin
John Broad et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Safety and Efficacy of Ulimorelin Administered Postoperatively to Accelerate Recovery of Gastrointestinal Motility Following Partial Bowel Resection: Results of Two Randomized, Placebo-Controlled Phase 3 Trials
Monica Shaw et al.
DISEASES OF THE COLON & RECTUM (2013)
Effect of Nortriptyline on Symptoms of Idiopathic Gastroparesis The NORIG Randomized Clinical Trial
Henry P. Parkman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Effect of mosapride on Kv4.3 potassium channels expressed in CHO cells
Ki-Wug Sung et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2013)
Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis
R. W. McCallum et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2013)
Influence of a neurokinin-1 receptor antagonist (aprepitant) on gastric sensorimotor function in healthy volunteers
D. Ang et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2013)
Why Can't Rodents Vomit? A Comparative Behavioral, Anatomical, and Physiological Study
Charles C. Horn et al.
PLOS ONE (2013)
Gastroparesis-Associated Refractory Nausea Treated with Aprepitant
Jon Fahler et al.
ANNALS OF PHARMACOTHERAPY (2012)
Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists
J. Broad et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting - randomised clinical study subset data
J. M. Wo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Domperidone Treatment for Gastroparesis: Demographic and Pharmacogenetic Characterization of Clinical Efficacy and Side-Effects
Henry P. Parkman et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
The translational value of rodent gastrointestinal functions: a cautionary tale
Gareth J. Sanger et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
The pharmacology of TD-8954, a potent and selective 5-HT4 receptor agonist with gastrointestinal prokinetic properties
David T. Beattie et al.
FRONTIERS IN PHARMACOLOGY (2011)
Comparison of selective M3 and nonselective muscarinic receptor antagonists on gastrointestinal transit and bowel habits in humans
Adil E. Bharucha et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study
N. Ejskjaer et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
A case of severe, refractory diabetic gastroparesis managed by prolonged use of aprepitant
Kiang Chong et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
Translating 5-HT4 receptor pharmacology
G. J. Sanger
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
Motilides: A long and winding road Lessons from mitemcinal (GM-611) on diabetic gastroparesis
Hisanori Takanashi et al.
REGULATORY PEPTIDES (2009)
A randomized, placebo-controlled, crossover, double-blind trial of the NK1 receptor antagonist aprepitant on gastrointestinal motor function in healthy humans
J. L. Madsen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
A systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis
Aravind Sugumar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
The in vitro pharmacological profile of TD-5108, a selective 5-HT4 receptor agonist with high intrinsic activity
J. A. M. Smith et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
Serotonergic signalling in the stomach and duodenum of patients with gastroparesis
N. Van Lelyveld et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2008)
Treatment options for patients with severe gastroparesis
Hasse Abrahamsson
GUT (2007)
Ghrelin selectively reduces mechanosensitivity of upper gastrointestinal vagal afferents
Amanda J. Page et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Tricyclic antidepressants for chronic vomiting in diabetic patients
Mandeep S. Sawhney et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Identification of neurons that express 5-hydroxytryptamine4 receptors in intestine
Daniel P. Poole et al.
CELL AND TISSUE RESEARCH (2006)
Treatment of gastroparesis: a multidisciplinary clinical review
TL Abell et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2006)
Functional roles of 5-hydroxytryptamine 3/4 receptors in neurons of rat dorsal motor nucleus of the vagus
E. Fukushi et al.
NEUROSCIENCE (2006)
Prokineticin-2, motilin, ghrelin and metoclopramide: Prokinetic utility in mouse stomach and colon
AK Bassil et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Differences in the sensorimotor response to distension between the proximal and distal stomach in humans
KJ Lee et al.
GUT (2004)
Stereocontrolled dopamine receptor binding and subtype selectivity of clebopride analogues synthesized from aspartic acid
E Einsiedel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
HI-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs
WK Kroeze et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction
PLR Andrews et al.
CURRENT OPINION IN PHARMACOLOGY (2002)
Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics
WA Volberg et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Effects of 5-HT3 antagonism on postprandial gastric volume and symptoms in humans
B Kuo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Does intravenous ondansetron affect gastric emptying of a solid meal, gastric electrical activity or blood hormone levels in healthy volunteers
P Netzer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Effects of CP-99, 994, a tachykinin NK1 receptor antagonist, on abdominal afferent vagal activity in ferrets:: evidence for involvement of NK1 and 5-HT3 receptors
M Minami et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound
MR Briejer et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
分享论文
